TIDE analysis showed that OSCC patients had higher TIDE scores when AURKA was highly expressed (Figure 2N–O), suggesting that OSCC tumor cells are prone to immune escape and less likely to benefit from immunotherapy in the presence of high AURKA expression. This evidence concerns the gene AURKA and neoplasm.